Therefore, the study cohort may not represent the entire T1a/bN0 population and represents patients to whom aCT was considered, younger patients or those with a more luminal B-like phenotype BC (defined by grade 2–3, lower progesterone receptor expression and a higher cell proliferation) associated with an inferior outcome. The gene discussed is PGR; the disease is breast cancer.